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Purpose/Objective: To evaluate if the time interval between 
capecitabine intake and radiotherapy(RT) affect survival 
outcome of locally advanced rectal cancer. 
Materials and Methods: 223 patients with locally advanced 
rectal cancer who received preoperative chemoradiation 
from January 2002 to May 2006 were included in current 
analysis. All patients had undergone pelvic radiotherapy 50 
Gy in 25 fractions with a daily dose of 1,650 mg/m2 of 
capecitabine twice a day at 12-hour intervals. Patients were 
classified into two groups. Group A included patients who 
took capecitabine 1 hour before radiotherapy, and group B 
included all other patients. 
Results: The median follow-up period was 72 months. 
Although group A had significantly higher good response rates 
(47% vs. 24%, p=0.001), 5-year OS was 85% in group A and 80% 
in group B with no significance.(p=0.529) Rate of 5-year local 
control, distant control, disease free survival were nearly 
identical in two groups. 
Conclusions: No difference was observed between the 
survival rates of both groups, despite the better pathologic 
response in group A. Further evaluations are needed to 
identify the interaction of capecitabine and RT.  
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Purpose/Objective: The aim was to evaluate whether 
elective inguinal irradiation during neoadjuvant 
chemoradiation leads to better inguinal nodal control than 
those obtained by neoadjuvant chemoradiation without 
inguinal irradiation in low-lying rectal cancers.  
Materials and Methods: A total of 102 patients with 
histopathologically proven low-lying rectal adenocarcinoma, 
who had radiological negative inguinal nodes were treated 
with (a) elective inguinal irradiation (43 patients), and (b) 
without elective inguinal irradiation (59 patients) during 
neoadjuvant chemoradiation. Data regarding the occurrence 
of inguinal nodal failure was recorded. 
Results: Median follow-up was 58.2 months (25-76). Four 
patients (3.9%) developed inguinal nodal recurrences; three 
of four cases had no elective inguinal irradiation (5.1%), and 
only one patient received elective inguinal irradiation (2.3%); 
p = 0.03. Median time to occurrence of inguinal nodal failure 
was 53.5 months (50-58). Three inguinal nodal failures were 
observed synchronously with metastatic disease, and were 
treated with systemic chemotherapy. Only one case of 
isolated inguinal nodal failure was salvaged successfully. 
Overall inguinal nodal control was 89.4%; elective inguinal 
irradiation (95.5%) and no elective inguinal irradiation 
(83.4%), p = 0.03.  
Conclusions: Elective inguinal irradiation was found 
beneficial in low-lying rectal adenocarcinoma especially 
those invading dentate line; however large randmized trials 
are warranted. 
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Purpose/Objective: This study evaluated outcomes in unfit 
locally advanced rectal cancer patients who received a short-
course (5 x 5 Gy) pre-operative RT followed by delayed 
surgery. 
Materials and Methods: From January 2007 to December 
2012 the study recruited 56 patients (37 male, 19 female; 
median age 79 years –range 51-93; median KPS status 90%, 
range 60-100%). Clinical tumour stage, evaluated by CT scan, 
endorectal US ± pelvic MRI was T3N0 in 19 and T3N1-2 in 37. 
Co-morbidities were classified according to modified 
Charlson’ index. RT volumes included the primary tumour, 
the correspondent mesorectum and diseased lymph nodes 
plus a 2 cm margin. All patients were treated with a 3DCRT. 
The Kaplan-Meier method estimated probability of loco-
regional relapse-free survival (LRFS), distant metastases-free 
survival (DMFS) and cancer-specific survival (CSS). Univariate 
analysis investigated the effects of age, grading, TRG and 
pathological stage on loco-regional relapse, metastases, and 
tumour-related death. Prognostic factors were included in 
proportional hazard multivariate models. Toxicity was 
evaluated on the RTOG/EORTC scale. 
Results: All patients completed the scheduled treatment. 
Surgery was performed in 46 patients (83%) at a median of 9 
weeks (range 5-16). Ten (17%) patients did not proceed to 
surgery (refusals or worsening co-morbidities). Thirty-three 
patients (71.7%) received anterior resection and 13 (28.3%) 
abdomino-perineal excision. TRG1 and TRG2 (Mandard scale) 
responses were achieved in 21 patients (47.6%) with TRG1 in 
7 (15.2%). Local recurrence developed in 3/46 patients after 
surgery. Overall 8 patients developed metastases. At a 
median follow-up of 30 months 29 patients (52%) are alive 
